Literature DB >> 24214580

Significance of the learning curve in left atrial appendage occlusion with two different devices.

Ignacio Cruz-Gonzalez1, Angel Perez-Rivera, Rosana Lopez-Jimenez, Javier Rodriguez-Collado, Javier Martín-Moreiras, Manuel Cascon, Antonio Arribas, Jose Carlos Gomez, Andrew O Maree, Candido Martin-Luengo.   

Abstract

OBJECTIVE: To evaluate the impact of learning on outcome with use of two different left atrial appendage (LAA) occlusion devices.
BACKGROUND: Two self-expanding devices, the Watchman and the Amplatzer Cardiac Plug (ACP), have been used for LAA occlusion in the last few years. It has been demonstrated that complications associated with implantation decrease in frequency with operator experience. However, the role of operator experience has not been compared across the two device types.
METHODS: The study comprises 31 consecutive patients who underwent LAA occlusion. We compare the first 10 patients in whom an ACP was implanted with the subsequent eleven patients who underwent ACP implantation and with 10 cases where a Watcthman device was implanted. The composite safety end point comprised procedure-related events and excessive bleeding events. We also performed 3 months echocardiographic and clinical follow-up.
RESULTS: There were not significant differences in the basal clinical and echocardiographical characteristics across the three groups. Cardiac complications only occurred in the ACP initial experience group (9% vs. 0% vs. 0% P = 0.04). Echocardiographic and clinical follow-up at 3 months was completed in all patients. No significant residual leak was detected. One patient in the ACP initial experience group developed a thrombus on the device. One patient in ACP late experience presented an ischemic stroke.
CONCLUSIONS: Complications associated with LAA occlusion cluster early in the peri-procedural period and significantly decrease in frequency with operator experience. Initial experience gained with one of device may improve outcome with use of alternative LAA occlusion devices.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  complications; learning curve; left atrial appendage

Mesh:

Year:  2013        PMID: 24214580     DOI: 10.1002/ccd.25230

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

Review 1.  Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation.

Authors:  Jawad Kiani; David R Holmes
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

2.  Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.

Authors:  Apostolos Tzikas; David R Holmes; Sameer Gafoor; Carlos E Ruiz; Carina Blomström-Lundqvist; Hans-Christoph Diener; Riccardo Cappato; Saibal Kar; Randal J Lee; Robert A Byrne; Reda Ibrahim; Dhanunjaya Lakkireddy; Osama I Soliman; Michael Nabauer; Steffen Schneider; Johannes Brachmann; Jeffrey L Saver; Klaus Tiemann; Horst Sievert; A John Camm; Thorsten Lewalter
Journal:  Europace       Date:  2016-08-18       Impact factor: 5.214

3.  Position Statement of the Brazilian Cardiology Society and the Brazilian Society of Hemodynamics and Interventional Cardiology on Training Centers and Professional Certification in Hemodynamics and Interventional Cardiology - 2020.

Authors:  José Airton de Arruda; Viviana de Mello Guzzo Lemke; José Mariani Júnior; Adriano Henrique Pereira Barbosa; Alexandre Schaan de Quadros; Carlos Augusto Cardoso Pedra; Cristiano de Oliveira Cardoso; Ênio Eduardo Guérios; Henrique Barbosa Ribeiro; Luiz Antonio Gubolino; Maurício Cavalieri Machado; Mauricio Jaramillo Hincapie; Nelson Antonio Moura de Araujo; Raul Ivo Rossi Filho; Ricardo Alves da Costa; Silvio Gioppato
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

4.  Comparative Safety and Efficacy of Left Atrial Appendage Occlusion with the Watchman Device and Amplatzer Cardiac Plug: Results of the Russian National Registry.

Authors:  Karapet Davtyan; Georgiy Simonyan; Arpi Topchyan; Andrey Kalemberg; Alexander Romanov; Vitaliy Shabanov; Dmitriy Lebedev; Sergey Gureev; Yulia Miller; Evgeniy Merkulov; Dmitry Pevzner; Pavel Mozgovoy; Vladimir Ufimtsev; Sergey Boytsov; Oksana Drapkina
Journal:  Biomed Res Int       Date:  2020-11-07       Impact factor: 3.411

5.  Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry.

Authors:  Ignacio Cruz-González; Francisco Torres Saura; Blanca Trejo-Velasco; José Antonio Fernández Díaz; Ricardo Fajardo Molina; Raquel Del Valle-Fernández; Gerardo Moreno Terribas; David Martí Sánchez; José-Ramón López-Mínguez; Ivan Gomez-Blazquez; Juan-Carlos Sanmartin Pena; Javier Botas; Pedro Martin Lorenzo; Jorge Palazuelos; Ramón Albarrán Rincon; Mohsen Mohandes; Felipe-Jose Rodriguez Entem; Gerard Martí; Ernesto Valero; Hipólito Gutiérrez; Ignacio J Amat-Santos; Luis Nombela-Franco; Pablo Salinas; Luis Teruel; Joan-Antoni Gomez-Hospital; Dabit Arzamendi; Mario Torres Sanabria; Germán Calle Pérez; Dolores Cañadas Pruaño; Armando Pérez de Prado; Tomás Benito González; Eduardo Arroyo-Úcar; Rodrigo Estévez-Loureiro; Berenice Caneiro-Queija; Jose L Ibañez Criado; Juan M Ruiz-Nodar
Journal:  Int J Cardiol Heart Vasc       Date:  2021-12-29

Review 6.  Left atrial appendage closure devices.

Authors:  Jorge Romero; Irving E Perez; Andrew Krumerman; Mario J Garcia; Richard J Lucariello
Journal:  Clin Med Insights Cardiol       Date:  2014-06-10

7.  Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study.

Authors:  Christian Fastner; Michael Behnes; Benjamin Sartorius; Mustafa Yildiz; Kambis Mashayekhi; Ibrahim El-Battrawy; Ralf Lehmann; Stefan Baumann; Tobias Becher; Martin Borggrefe; Ibrahim Akin
Journal:  BMC Cardiovasc Disord       Date:  2016-01-28       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.